Statins for atherosclerotic cardiovascular disease prevention in people living with HIV in Thailand: a cost-effectiveness analysis.

David Charles BoettigerAnthony T NewallPairoj ChattranukulchaiRomanee ChaiwarithSuwimon KhusuwanAnchalee AvihingsanonAndrew N PhillipsEran BendavidMatthew G LawJames G KahnJeremy RossSergio Bautista-ArredondoSasisopin Kiertiburanakul

Published in: Journal of the International AIDS Society (2021)

Neither pravastatin nor pitavastatin were projected to be cost-effective for the primary prevention of CVD among PLHIV in Thailand who are not currently using lipid-lowering therapy. We do not recommend expanding current use of these drugs among PLHIV in Thailand without substantial price reduction.

Keyphrases

cardiovascular disease
type diabetes
climate change
stem cells
fatty acid
cardiovascular events
cardiovascular risk factors
cell therapy
smoking cessation
chemotherapy induced